Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $33.17B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2026 · Mkt cap
Decision snapshot: DXCM stock price vs KSS: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at KSS's multiple
Needs KSS P/E.
Implied fair value · at DXCM's multiple
Needs DXCM P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: DXCM FY 2025 (ended Dec 31, 2025) · KSS FY 2026 (ended Jan 31, 2026). Fiscal years are not aligned.
Trendline
11 fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 91% equity / 9% debt · EV / Revenue 7.63x · EV / EBITDA 26.75x
Capital structure 61% equity / 39% debt · EV / Revenue 0.19x · EV / EBITDA 4.70x
DXCM carries the larger enterprise value at $35.57B against $2.97B; KSS trades on the lower EV / Revenue multiple (0.19x vs 7.63x); KSS on the lower EV / EBITDA (4.70x vs 26.75x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
DEXCOM, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
KOHL’S CORP · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.21x
0.35x
Net debt / EBITDA
Leverage against operating earnings
1.81x
1.21x
Cash and equivalents
Liquid reserves on the balance sheet
$917.70M
$674.00M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
ABBOTT LABORATORIES
DXCM vs ABT
Medtronic plc
DXCM vs MDT
BECTON DICKINSON & CO
DXCM vs BDX
TJX COMPANIES INC /DE/
DXCM vs TJX
ROSS STORES, INC.
DXCM vs ROST
Concrete Pumping Holdings, Inc.
DXCM vs BBCP
NORDSTROM INC
DXCM vs JWN
Walmart Inc.
DXCM vs WMT
COSTCO WHOLESALE CORP /NEW
DXCM vs COST
$3.32B
$1.44B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
